Cost effectiveness analysis of inhaled anticholinergics for acute childhood and adolescent asthma

British Medical Journal

Volumn 319, Issue 7223, 1999, Pages 1470-1471

  Lord, Joanne ^a   Ducharme, Francine M ^b   Stamp, Ronald J ^c   Littlejohns, Peter ^a   Churchill, Rachel ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID;

ADOLESCENT; ARTICLE; ASTHMA; BRONCHODILATATION; CHILD; CHILDHOOD DISEASE; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; EMERGENCY WARD; HEALTH CARE PLANNING; HOSPITAL ADMISSION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK; TREATMENT INDICATION;

EID: 0033524144     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.319.7223.1470     Document Type: Article

References (5)

1. 2 agonists for treating acute childhood and adolescent asthma? A systematic review. BMJ 1998;317:971-7.
2. 2 Briggs A, Sculpher MJ, Buxton MJ. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Economics 1994;3:95-101.
3. 3 Lord J, Asante MA. Estimating uncertainty ranges for costs by the bootstrap procedure combined with probabilistic sensitivity analysis. Health Economics 1999;8:323-33.
4. 4 Partridge MR, Latouche D, Trako E, Thurston JGB. A national census of those attending UK accident and emergency departments with asthma. J Accident Emerg Med 1997;14:16-20.
5. 5 Stell IM. Asthma management in accident and emergency and the BTS guidelines - a study of the impact of clinical audit. J Accident Emerg Med 1996;13:392-4.